RecruitingNot ApplicableNCT04512456

Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training

Autonomic and Hemodynamic Responses to Muscular Ergoreflex Activation in People Living With HIV/AIDS: Effects of Exercise Training.


Sponsor

Instituto Nacional de Cardiologia de Laranjeiras

Enrollment

63 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Patients living with HIV (PLWHIV) have compromised muscle metaboreflex, which can cause exercise intolerance. This randomized controlled clinical trial will verify the effects of regular exercise on autonomic and hemodynamic responses to muscle ergoreflex activation in these patients. PLWHIV without regular physical exercise will be randomly assigned into an exercise training or a control group. The exercise training group will undergo regular physical exercise during 12 weeks (60-min session performed 3 times/wk with moderate intensity), while the control group will keep inactive. Another group consisted of inactive HIV-uninfected group will be included. The primary endpoints will be blood pressure and autonomic markers in response to the Stroop Color-Word Test and the activation of muscle ergoreflex, by means of the post-exercise circulatory arrest (PECA), which will be performed with and without the topical application of a capsaicin-based analgesic balm. Secondary endpoints will include heart rate, peripheral vascular resistance, stroke volume, cardiac output, blood lactate concentration, anthropometrics, and handgrip strength. The active and inactive PLWHIV groups will be evaluated before and after the exercise training, while the healthy group only at baseline.


Eligibility

Min Age: 30 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study examines how the heart and blood vessels respond to exercise in people living with HIV who are on long-term antiretroviral therapy (HIV medications), and whether a structured exercise training program can improve heart health in this population. **You may be eligible if...** - You have had an HIV diagnosis for at least 5 years - You have been on combination antiretroviral therapy (HIV medications) for at least 3 years - You are currently free of symptoms and opportunistic infections - You are not currently doing regular exercise **You may NOT be eligible if...** - You have coronary artery disease, pulmonary disease, diabetes, or Chagas disease - You are malnourished - You exercise regularly already - You have other serious health conditions that would make exercise unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExercise training

Exercise training performed during 12 weeks, 3 sessions per week of 60 minutes of strength and aerobic exercises.


Locations(1)

Rio de Janeiro State University

Rio de Janeiro, Rio de Janeiro, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04512456


Related Trials